Literature DB >> 8783998

Adverse effects of postoperative infusion of shed mediastinal blood.

R A Vertrees1, V R Conti, S D Lick, J B Zwischenberger, L B McDaniel, G Shulman.   

Abstract

BACKGROUND: Postoperative infusion of shed mediastinal blood has been used in an effort to decrease blood usage after cardiac operations. Recent experience has suggested that this practice may actually lead to a delayed increase in bleeding.
METHODS: In a prospective, randomized study, 40 patients undergoing coronary artery bypass grafting with shed mediastinal blood collected in a cardiotomy reservoir were divided into two equal groups and studied during their first 4 hours in the intensive care unit. Shed mediastinal blood was directly infused in group I (n = 20), whereas in group II (n = 20), it was not. In group II, if a sufficient volume of red cells was present to allow processing (n = 5), washed red cells were infused. Variables studied before and after infusion were the amount of blood lost and infused, homologous blood transfused, complete blood count and differential, serum fibrinogen, fibrin split products, D-dimers, clotting factors, prothrombin time, activated partial thromboplastin time, thromboelastograms, plasma-free hemoglobin, complement factors C3 and C4, creatine kinase and its MB isoenzyme, and body temperature.
RESULTS: After infusion of shed mediastinal blood, elevated levels of fibrin split products and D-dimers were found in significantly more patients in group I. The thromboelastogram index was normal in 76% of patients in group II but in only 12.5% in group I. Group I also had an increase in band neutrophils, a greater number of febrile patients, higher serum levels of creatine kinase, its MB isoenzyme, and plasma-free hemoglobin, and greater blood loss during hours 3, 4, and 5 in the intensive care unit. The volume of red cells in shed mediastinal blood (hematocrit, 9% to 10%) was small, resulting in clinically insignificant autotransfusion when infused directly, and insufficient for cell processing in most patients.
CONCLUSIONS: These data support those in previous studies that direct infusion of shed mediastinal blood does not save substantial amounts of autologous red cells and can cause a delayed coagulopathy and other adverse effects that may be harmful to patients postoperatively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783998     DOI: 10.1016/s0003-4975(96)00390-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Cell salvage for minimising perioperative allogeneic blood transfusion.

Authors:  Paul A Carless; David A Henry; Annette J Moxey; Dianne O'Connell; Tamara Brown; Dean A Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

2.  [Blood conservation effect and safety of shed mediastinal blood autotransfusion after cardiac surgery].

Authors:  T Komiya; K Ban; K Yamazaki; O Date; T Nakamura; Y Kanzaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-10

3.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

4.  Dynamic changes in clot formation determined using thromboelastometry after reinfusion of unwashed anticoagulated cell-salvaged whole blood in total hip arthroplasty.

Authors:  Bernd Froessler; Ingo Weber; Nicolette A Hodyl; Khaschayar Saadat-Gilani
Journal:  Blood Transfus       Date:  2015-06-12       Impact factor: 3.443

5.  Time-related hemolysis in stored shed mediastinal blood after cardiopulmonary bypass.

Authors:  Ken Nakamura; Koji Kawahito
Journal:  J Artif Organs       Date:  2011-01-18       Impact factor: 1.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.